…is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) therapeutics.
By leveraging our proprietary BioSymphony™ Platform, Oncobiologics is able to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.
We cost-effectively develop biosimilars candidates on an accelerated timeline
Our strategy includes developing innovative mAb candidates
We leverage our platform to provide development and manufacturing for development stage biotechnology firms